Delivered-To: pgepnewsletter@gmail.com
Received: by 2002:a05:640c:2d08:b0:1ee:5ffb:29ea with SMTP id p8csp228957eiu;
        Mon, 22 Jan 2024 16:46:16 -0800 (PST)
X-Google-Smtp-Source: AGHT+IHdZ4HSo90yQ3/MKNxo5DaRXfXgQ4XIvYJF1yjruI7EbgxJm2U5eigqXVbwGafYrF4l9wFu
X-Received: by 2002:a0d:e4c3:0:b0:5ff:4b64:890c with SMTP id n186-20020a0de4c3000000b005ff4b64890cmr3304101ywe.75.1705970776168;
        Mon, 22 Jan 2024 16:46:16 -0800 (PST)
ARC-Seal: i=1; a=rsa-sha256; t=1705970776; cv=none;
        d=google.com; s=arc-20160816;
        b=gAy/yZACrI70pUoGJiT6gtYG8OhgMC8ExaDliyvH76hHji5NHF5Ay9xKKk1k/5wvyQ
         p1X4kbVqd/m4YA9gTRWHODjWiH2Sqo9Ip8pQrXwuYTFzp90UbGH0mfwWGMwAETFBMex4
         WDOs6k/iyROKsBNhwc8LoJUDlJXcsMVOiYHsSUZFh466DlFkqTSJU2Bo6ZG6lib9HlQa
         izEklmL0t47BLXGWIUnN0YP7EnFcJ1oUxX4jR0kqHGjb917DhYxICPJa7B8DBGAtFQOZ
         d0ibHmRYrcvs+0Rks18piuyq76bxqT1zimOJ5hEY+IJ2emf0gSHQ7XddFGObEhwS+sxo
         0H8w==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=google.com; s=arc-20160816;
        h=list-unsubscribe:to:reply-to:subject:message-id:mime-version:from
         :date:dkim-signature:dkim-signature;
        bh=k1ncjBmL+4jHrtjhldBJFUO+Vc7O3IYm/4XNQ+d1L6A=;
        fh=m8+yFGL9AGrkSifADXzxzWHypeMVd9MF7/kbikeN2H4=;
        b=f37L+SVF761tBWg3ezK3xXLsxM2ID/RI64Wevp+JTXAqZSz+R5HieR1Y6IVggeL4I9
         XkfBygfVAAsnLjFCHwwbIH35L0nwqccxVrtP3bHx1giugSBAwaprI+Nt7RHjfPfuFtmU
         V5O4FLOeQ7y3k72wdIpcnoIGChgcavSp8667TS8w6HAxsosnvylQ3DlbqFdHlH6akxhe
         eMsPzH8SYbTK7W+5BMoc/CzfgkuCRyrX0Sq1BeSikVkCL1zlfTxGzHiTe2hoJs7wyMYa
         yR4LOzTYXpaSe3bkhPNkD/d7B+kdCVekFKnkZ5J8IJKo5/xJaN6I1Gd4Fz2hcY75uGif
         WKVQ==
ARC-Authentication-Results: i=1; mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=KzTXcP38;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=dND3HFQE;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
Return-Path: <bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org>
Received: from xtrwrkzn.outbound-mail.sendgrid.net (xtrwrkzn.outbound-mail.sendgrid.net. [167.89.81.226])
        by mx.google.com with ESMTPS id e19-20020ac85dd3000000b0042a3cb97070si3848148qtx.548.2024.01.22.16.46.16
        for <pgepnewsletter@gmail.com>
        (version=TLS1_3 cipher=TLS_AES_128_GCM_SHA256 bits=128/128);
        Mon, 22 Jan 2024 16:46:16 -0800 (PST)
Received-SPF: pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) client-ip=167.89.81.226;
Authentication-Results: mx.google.com;
       dkim=pass header.i=@isid.org header.s=s1 header.b=KzTXcP38;
       dkim=pass header.i=@sendgrid.info header.s=smtpapi header.b=dND3HFQE;
       spf=pass (google.com: domain of bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org designates 167.89.81.226 as permitted sender) smtp.mailfrom="bounces+19268662-547c-pgepnewsletter=gmail.com@em7004.isid.org";
       dmarc=pass (p=NONE sp=NONE dis=NONE) header.from=isid.org
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=isid.org;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=s1; bh=k1ncjBmL+4jHrtjhldBJFUO+Vc7O3IYm/4XNQ+d1L6A=;
	b=KzTXcP38YUqaYBqp59kIR70MHg9Ypw8ZZoYPxWpUcQr8kC3zTUX4XK5t1BOY4mgYxls9
	/i+rodoqS3q8tETKdgcbpF0N0NG422W5XbnTtmpLreXel28sriaeWJzFU33KFcXczhzx2E
	s3hQ3gqG2/qgFqirbFu0rrGwQhO5b4dFRjNjpwK6TzENtImjYCjw7JeIk05iKbc2UsBf6y
	MYv97VphLRVXZ6NfUg5MtHSK1/B+iSBIPeRp5/C/2wb1Vq5wzEjYkmcl++MvG19BBL1FwJ
	pqOpM30fVJqVBUbcx4JW+JlF9k14GMxTBqiIcxEvlSodT9Q9hIEIToGbbmpXVH7A==
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=sendgrid.info;
	h=content-type:from:mime-version:subject:reply-to:x-feedback-id:to:
	list-unsubscribe:cc:content-type:from:subject:to;
	s=smtpapi; bh=k1ncjBmL+4jHrtjhldBJFUO+Vc7O3IYm/4XNQ+d1L6A=;
	b=dND3HFQEF1JXfRru1dmgzwcxFoJO2T/mjc5VF0leJelo6EFuTf2hwShm4+FEVQnxUduw
	pygfloeu2d17BiQsbnr2H8ODmDMw65atDSRNRJktAqlYFoQyUNsD7Ri+x5tGz7i3mLkF3h
	O8ttDdMjibwuCLj/i/HOlLoN7V9qtAPFA=
Received: by filterdrecv-74bdf4d586-xvxm2 with SMTP id filterdrecv-74bdf4d586-xvxm2-1-65AF0C57-4F
        2024-01-23 00:46:15.790432719 +0000 UTC m=+8402670.504567569
Received: from MTkyNjg2NjI (unknown)
	by geopod-ismtpd-14 (SG) with HTTP
	id LT_g2aCiSZasMZxYvxfcRA
	Tue, 23 Jan 2024 00:46:15.765 +0000 (UTC)
Content-Type: multipart/alternative; boundary=57899cb04cf9603f952a0bc9d5adb4b0830e7f75d6d524e7f485349e700b
Date: Tue, 23 Jan 2024 00:46:15 +0000 (UTC)
From: ProMED <promed@isid.org>
Mime-Version: 1.0
Message-ID: <LT_g2aCiSZasMZxYvxfcRA@geopod-ismtpd-14>
Subject: PRO/EDR> Malaria - Venezuela: (FN, AM) indigenous people
Reply-To: noreply@isid.org
X-Feedback-ID: 19268662:SG
X-SG-EID: 
 =?us-ascii?Q?lYKUi1ucKQwcfoVB1xAcbBSlsJP9QSi7ed2VWI0p5NjpCc5BQK+kujBGGO1mU1?=
 =?us-ascii?Q?iBfQW24AiTaMaNoRKxfC3zYBSsz+ZKHUNa8Pend?=
 =?us-ascii?Q?JX=2FbOg1yLDw4fqrJGZd83tugmQa5VlW0Bs09CE7?=
 =?us-ascii?Q?OTU6sSfgSG449xEtPfTn93QjwtPoRQJa6VwvlZ4?=
 =?us-ascii?Q?icyWNgWq9RaYE9v3tcuu6w5B58M2q3pJ5XzX1eR?=
 =?us-ascii?Q?lOWUccuplJF7Wl=2FzRjT+4LjwNeA6R8ZwE4mN5q?=
X-SG-ID: 
 =?us-ascii?Q?se=2F49CGmbS0sfR97ImeXvNhg9p9jggtUUChgqoY2wUhc93xcG=2F095a5S4+mt=2FG?=
 =?us-ascii?Q?uYUpctI=2FOGD2dwyi+uvm2j4FCdvuw0l9zcHM8iA?=
 =?us-ascii?Q?mojOvTXq7jOpDFFNtfsYkHQYACEW8pq1BXXqYmH?=
 =?us-ascii?Q?oGTsnt6QpE2ZV5WVqnpwfXWoLXx7+4a7dsLqWcm?=
 =?us-ascii?Q?zepuQmlTLUojEM4ExNCbcO=2FFBRBMP7gIHHmryRF?=
 =?us-ascii?Q?DsQgQgMkr8AGCMt596LjVAF9iSI1+qdCcMC0=2FMn?=
 =?us-ascii?Q?w4Tf60OEvxPRdWlICZMeLWWAVDdAl9re1ut1WrQ?=
 =?us-ascii?Q?bB8s1zD4h+8FzE7Lbeqw=2FpZCDM4LyZugAwtN3HT?=
 =?us-ascii?Q?ZuVQbm4FRjmJOBu1f0JBp7d3lZcNh15LKpoLdsy?=
 =?us-ascii?Q?nG0TpAoM1xSdEDgIQ7o+GGvjckIib1JjDr4TaRA?=
 =?us-ascii?Q?H4gIvySawpuEHKLWw5NUIM3XJeVWpDK6vQAnBAX?=
 =?us-ascii?Q?P2iXTTBVzjwsjexeUF1uX09kUa8OLRk8jyw+nXw?=
 =?us-ascii?Q?qRr1rlUAeYRBiG4DG4EESG3pi2h6HoFrX0LSxjz?=
 =?us-ascii?Q?WTlbLXUyZTI8C=2FYO0+IgM8SYHcylKWjYSZe0cf+?=
 =?us-ascii?Q?jGEsXFtw1adIGHZaYIkm=2FS6xkzhHaYy3g0FGvws?=
 =?us-ascii?Q?0aPoUqjmeAHfzj=2FTypPoOHqYYylsa+QV7amRe+f?=
 =?us-ascii?Q?9vcxpwE=2F1WtYeZM7gYKKtOWWEtKVW7+3f7Ar717?=
 =?us-ascii?Q?TPUUuHMF3OKgKiWFrDi1G0HAOEfWfpbV6UVy+kJ?=
 =?us-ascii?Q?C45CbhvsEyqWI5KeGBLa48vCTUp2mGl5WDjvizd?=
 =?us-ascii?Q?alhpY6aeMq7dW1ACIp99Yzk9BA=3D=3D?=
To: pgepnewsletter@gmail.com
X-Entity-ID: 3CKJgmVGbBVD214dsRqreg==
List-Unsubscribe: 
 =?us-ascii?Q?=3Cmailto=3Aunsubscribe=40em7004=2Eisid=2Eorg=3Fsubject=3D19268662=2E0jpx0O3tM?=
 =?us-ascii?Q?5w7LQotEJeV7yeUkG4Daplgr4WPaQ3UwN9oMDAw?=
 =?us-ascii?Q?dTAwMDQL0VpMzc2VcgCsrPNOrZvn9QyWZTujZm0?=
 =?us-ascii?Q?hy7gqz4qgag4BOC6od63zZtjEwCujDZg3mufzWD?=
 =?us-ascii?Q?lxwcAkNYYqAWnJpdQBTEtZPIng4Xyd9fxX-auio?=
 =?us-ascii?Q?tYEex0iP0nBHyN-lQ=3D=3D=2EmR9iev2zEyJFNHcl=5Fld?=
 =?us-ascii?Q?MptxiTZ8x-su-23szY7eMUWFoMDAwdTAwMDryPX?=
 =?us-ascii?Q?JIjzmLfV9v31dbw9MMM7A6ZBsL=5FKGx3tSUBjgBi?=
 =?us-ascii?Q?eJ8D29Ou28MOZPGvueEOzC59LM7CeRTox5xmSJE?=
 =?us-ascii?Q?QvLHeBoeOv-VwLYbxLRyKawHpV32IbemBtCZszG?=
 =?us-ascii?Q?ygY18to852zLEC0L0oyGeuiSyrtn1pOsmzd8JBv?=
 =?us-ascii?Q?TfTLA=5F8Na8jsb2FP6wPCXfkU7HIPOOc3gCZSxOa?=
 =?us-ascii?Q?oY6Cr9V8YJCw2r5KTamxAyMKeUeMLSBfdbQidCs?=
 =?us-ascii?Q?rkEiXgcvz8GdvvMSCySboch1XNyjomGvFnGf2pL?=
 =?us-ascii?Q?H2sQ3ayyu7XlrlMyLwS4JLxo15Oy6Pfirzb=5FUxT?=
 =?us-ascii?Q?b94Cffpk5rqXcqWdwcEozJR8EymBOcLJ0z0iWZk?=
 =?us-ascii?Q?tbDPaVJAIBKxIbpi8WG-u81PNsjNV=5FYYE8BwXxZ?=
 =?us-ascii?Q?Pea55GlG8mAoR6tfPfUywBADw8325dVJjp4mwWq?=
 =?us-ascii?Q?vA-sWkU5BIm5O3Z6dISRzoTIb1kocxtL=5Fk31I0n?=
 =?us-ascii?Q?HbKz95f9KLkfK5mtPa4kOiNJKVR0L4MLdxtMfrU?=
 =?us-ascii?Q?4Hhu1WqsPbOaG099Hnu9Iqri1Qyrg856qEJooCM?=
 =?us-ascii?Q?yusS63cJgOL-U5AP91sEX1Bw9Qsw4BZFG-Mbw5H?=
 =?us-ascii?Q?VpbiS4=5FNpFXVh1hBGQKL9Lfy1AsPlW8Le=5F2=5F3OI?=
 =?us-ascii?Q?jlH8DGHczn82jrZrexRPw8xFvHZeWBSDWarvk=5FM?=
 =?us-ascii?Q?Qxv8-AWlv=5FXtYVwSQey7CVwREm81ZlsBoznvLJg?=
 =?us-ascii?Q?ewFLB5pyqpD6jA0b=5FJFWUV46n3k8r1fv1cZtisJ?=
 =?us-ascii?Q?PBCw1zLBu7fhLdjRhyaenBL6d71Pp7617oXlpKQ?=
 =?us-ascii?Q?i0b=5FrW4iSBYw10-w=5F3U6W660KvcHisBu94HkKUj?=
 =?us-ascii?Q?KXU1akX7isFv8S4twN=5F34Bak3g=5FBSgevU2qUXlH?=
 =?us-ascii?Q?65bjUcYSP5O7Mq1E7agqbOisQk=5FycWZNwnfmOz9?=
 =?us-ascii?Q?tMGh-RmG0BkKncM9PEy8qk4dlo7aBX5bm9jG1Ex?=
 =?us-ascii?Q?zL9dlrvwsp6uj8BVmctBSqVHRmnpscFgFRRr7LJ?=
 =?us-ascii?Q?RXunMAllLg5Og6bmb5xot7m=3E?=

--57899cb04cf9603f952a0bc9d5adb4b0830e7f75d6d524e7f485349e700b
Content-Transfer-Encoding: quoted-printable
Content-Type: text/plain; charset=utf-8
Mime-Version: 1.0

MALARIA - VENEZUELA: (FALCON, AMAZONAS) INDIGENOUS PEOPLE
*********************************************************
A ProMED-mail post
<http://www.promedmail.org>
ProMED-mail is a program of the
International Society for Infectious Diseases
<http://www.isid.org>

Date: Sun 21 Jan 2024
Source: El Clar=C3=ADn [machine trans., edited]
<https://elclarinweb.com/alerta-epidemiologica-resurgimiento-mortal-de-mala=
ria-en-comunidades-yanomami/>


Epidemiological alert: deadly resurgence of malaria in Yanomami
communities
---------------------------------------------------------------------------
Venezuela faces an alarming resurgence of malaria. The report by the
NGO SOS Orinoco reveals the tragic reality: 85 Yanomami indigenous
people have lost their lives due to malaria in various communities in
the Sierra Parima, Amazonas State. Names like Momoi, Aranai, and
Shamauka are now symbols of the devastation this outbreak has left in
its wake. Epidemiologist Francisco Leal warns that malaria has also
become endemic in the state of Falc=C3=B3n, pointing out that this
infectious disease persists in the region, permanently affecting the
population. This situation could lead to Falc=C3=B3n being declared the
17th Venezuelan state endemic for malaria.

The cases are concentrated in the southern area of western Falcon,
specifically in Dabajuro, Buchivacoa and Mene de Mauroa. Health
authorities have confirmed 134 cases, 86 of which are native and 48
from Zulia. The lack of surveillance and control of the health system
is blamed for the outbreak. Specialist Francisco Leal, with his vast
experience, points out that the outbreak in Falc=C3=B3n is the result of
failures in the surveillance and control system. The need to
characterize, map and control the case mix of patients is highlighted
as a priority to avoid future episodes.

The current outbreak marks a grim record for Falc=C3=B3n, being the
highest since 2019. Leal highlights that, since then, there was no
certainty about the indigenous nature of the cases, underscoring the
urgency of addressing and preventing future outbreaks. The increase in
cases and deficiencies in the health system response raise questions
about the effectiveness of control measures. The vulnerability of
indigenous communities and the need for immediate action resonate as
crucial challenges in the fight against malaria.

--
Communicated by:
ProMED
via=20
ProMED-ESP

[The history of Venezuela's experiences with malaria is discussed
here:

Gabald=C3=B3n-Figueira JC, Villegas L, Grillet ME, et al. Malaria in
Venezuela: Gabald=C3=B3n's legacy scattered to the winds. Lancet Glob
Health. 2021 May;9(5):e584-e585. doi: 10.1016/S2214-109X(21)00007-3.
<https://pubmed.ncbi.nlm.nih.gov/33865468/> (References can be found
at the original URL)
---------------------------------------------------------------------------=
-----
"Between 1936 and 1970, Venezuela enacted one of the most important
sanitary campaigns against malaria. It was led by Arnoldo Gabald=C3=B3n,
and its cornerstone was a national indoor residual spraying campaign
with dichlorodiphenyltrichloroethane that lasted for almost 4 decades.
By 1961, malaria had been wiped out from 68% of the Venezuelan
territory, and the mortality rate had been reduced from 164 deaths per
100=E2=80=88000 people in 1936 to zero in 1962 (1,2). The partial
elimination of the disease earned Venezuela an increase of over
400=E2=80=88000 km2 in its commercially exploitable territory (1). an area
twice as large as the UK. This additional land proved fundamental for
Venezuela's economic development during the 2nd half of the 20th
century.

The current situation could not be more different: the 2020 World
Malaria Report estimates that 467=E2=80=88421 cases of malaria occurred in
Venezuela in 2019 -- a 1200% increase compared with the year 2000 (3).
Venezuela's incidence of 32.8 per 1000 people at risk is 8 times
higher than that of neighboring Brazil, and comparable to that of
Ethiopia (34 cases per 1000 people at risk). Mortality figures are
similarly striking. With 403 deaths in 2019, Venezuela accounted for
73% of the total deaths from malaria estimated on the continent (3).

The epicentre of the epidemic is the mining regions south of the
Orinoco river (4) where conventional health care is often no longer
available. This unavailability makes local Amerindian groups
particularly susceptible, given their poor access to preventive
measures and antimalarial treatment.

The World Malaria Report shows that the situation in Venezuela is
anomalous in the global context, with substantial progress achieved
elsewhere. Furthermore, the scale of the epidemic, combined with
migration from Venezuela into neighboring countries, makes this
malaria crisis a regional problem, and is driving Latin America
severely off track in meeting WHO's milestones for the 2016-30 period.
(3,5). If the current trend is sustained, the region might reach 12
cases of malaria per 1000 people at risk by 2030, in striking contrast
with the projected reduction in areas with a higher malaria burden.
Yet, international attention and support are scant, because of a
long-outdated understanding of Venezuela as an affluent country.

Because of the economic gains attained through its oil riches and the
exploitation of malaria-free territories in the 1950s, the World Bank
has long labelled Venezuela as an upper-middle-income country. That
classification has not been changed, even though the estimated
percentage of people living below the extreme poverty line (defined at
USD 1.9 per day) reached 54=C2=B76% in 2019 (6).

The current income classification is probably out of date. Between
2013 and 2020, the Venezuelan economy has shrunk by an estimated 74%
(7), but the World Bank classification has yet to account for the last
2 years. The newest edition, published in July 2020, is based on
economic data from mid-2019.(8) If there were full accounting for the
past 7 years of economic contraction, Venezuela's per-person income
would be well under the threshold to be classified as a lower
middle-income country.

The upper-middle-income classification constrains or, in some cases,
outright prohibits assistance from key funders of malaria research and
control. The Global Fund to fight AIDS, Tuberculosis and Malaria for
instance, did not consider Venezuela to be eligible for malaria
funding until 2019, when it was exceptionally included for the 2020-22
allocation period based on its high malaria burden. At least USD 19.8
million is expected to be disbursed to the country in 2021 (9).
Despite this, Venezuela still is not prioritized by other key
funders.

Furthermore, although the Global Fund's decision is a key step, there
is concern over how the funds will be managed, given obstacles
ensuring public health neutrality in the context of humanitarian
crisis and the political control of social aid programmes by the
Venezuelan Government (10).

To ensure a democratic use of these resources, allocation strategies
should involve the Venezuelan medical and scientific community and
civil society organizations in the design, monitoring, and evaluation
of any interventions. Government participation should be conditional
on the release of epidemiological data (which has been absent since
2016), the cessation of the persecution of non-governmental
organizations providing humanitarian support, and the acceptance of
international accountability for disease control efforts.

Paradoxically, we expect malaria cases to decrease in 2020, as
mobility restrictions, caused by the COVID-19 pandemic and national
fuel shortages, have probably reduced local transmission in mining
sites. Additionally, a few non-governmental organizations together
with the Pan-American Health Organization have made substantial
efforts to distribute insecticide-treated nets in some of the higher
burden areas, in addition to the tireless surveillance and control
endeavors led by indigenous community health agents.

The epidemic, however, will not be brought under control without a
functional national malaria program in place. Ironically, it was the
success of such a previous program that led to the economic boom now
preventing Venezuelan researchers from accessing urgently needed
resources. It is time for this painful irony to end." - Mod.LL

ProMED map:
Venezuela: <https://promedmail.org/promed-post?place=3D8714399,29>]

[See Also:
Malaria - Argentina: (Buenos Aires) imported, USA citizen, fatal
http://promedmail.org/post/20240118.8714316
Malaria - Cape Verde: elimination, WHO
http://promedmail.org/post/20240117.8714283
Malaria - USA (01): (OR) falciparum, probable prolonged presentation,
ex Africa, 2022 http://promedmail.org/post/20240113.8714202
Malaria - Tanzania: (Zanzibar) re-emergence
http://promedmail.org/post/20240113.8714213
2023
----
Malaria - Asia (09): India (WB)
http://promedmail.org/post/20231215.8713751
Malaria - Asia (07): India (TR) increased cases
http://promedmail.org/post/20231018.8712705
Malaria - Americas (16): USA (MD) autochthonous, falciparum, CDC
http://promedmail.org/post/20231012.8712600
Malaria - Americas (15): (Canada) ex Philippines, Plasmodium knowlesi
http://promedmail.org/post/20231007.8712508
Malaria - Americas (14): USA (AR) autochthonous
http://promedmail.org/post/20231005.8712469
Malaria - Africa (07): Ethiopia (OR) continued increase, RFI
http://promedmail.org/post/20231001.8712408
Malaria - Americas (13): Costa Rica (PU)
http://promedmail.org/post/20230929.8712370
Malaria - Americas (12): USA (FL, TX) CDC
http://promedmail.org/post/20230908.8712013
Malaria - Americas (11): USA (MD) 1st report in 40 years
http://promedmail.org/post/20230819.8711760
Malaria - Americas (11): Colombia, increase in incidence
http://promedmail.org/post/20230723.8711323
Malaria - Americas (10): USA (FL) autochthonous
http://promedmail.org/post/20230718.8711230
Malaria - Americas (09): USA (FL, TX) autochthonous, update
http://promedmail.org/post/20230709.8711042
Malaria - Africa (06): Ethiopia, increase, RFI
http://promedmail.org/post/20230706.8710994
Malaria - Americas (08): USA (FL, TX) autochthonous, CDC, alert
http://promedmail.org/post/20230629.8710856
Malaria - Americas (07): USA (TX) autochthonous
http://promedmail.org/post/20230625.8710761
Malaria - Americas (06): USA (FL) autochthonous, RFI
http://promedmail.org/post/20230623.8710719
Malaria - Africa (05): Kenya (MB) fatal, not linked to Anopheles
stephensi http://promedmail.org/post/20230524.8710210
Malaria - Africa (04): Kenya (BN), Congo DR (KS), Nigeria (AN), Ghana
http://promedmail.org/post/20230502.8709805
Malaria - Americas (05): Colombia, Venezuela
http://promedmail.org/post/20230501.8709785
Malaria - Americas (04): USA, imported, ex Liberia, fatal
http://promedmail.org/post/20230427.8709737
Malaria - Americas (03): (Costa Rica, Panama)
http://promedmail.org/post/20230424.8709665
Malaria - Americas (02): Costa Rica (LI)
http://promedmail.org/post/20230409.8709416
Malaria - Americas: Panama, increase
http://promedmail.org/post/20230315.8708952]
.................................................jt/ll/may/jh
*##########################################################*
************************************************************
ProMED makes every effort to verify the reports that are posted, but the ac=
curacy
and completeness of the information, and of any statements or opinions base=
d
thereon, are not guaranteed. The reader assumes all risks in using informat=
ion
posted or archived by ProMED. ISID and its associated service providers sha=
ll not
be held responsible for errors or omissions or held liable for any damages =
incurred
as a result of use or reliance upon posted or archived material.
************************************************************
Donate to ProMED. Details available at: https://isid.networkforgood.com/pro=
jects/79924-invest-in-the-mission.
************************************************************
Visit ProMED's website at https://www.promedmail.org/.
Submit all items for posting via the ProMED website at https://promedmail.o=
rg/submitinfo/.
If you have any questions or need support, please contact us via the ProMED=
 website at  https://promedmail.org/support/.
You may subscribe/unsubscribe at  https://isid.org/promedmail-subscribe/.
Unsubscribe Preferences ( https://u19268662.ct.sendgrid.net/asm/?user_id=3D=
19268662&data=3DectqUzjpxOCQdwBqe10mLlG10Fgk9llFN9qxAE_jsypoMDAwdTAwMLZ61lE=
VOG2qTCLLXH7FICaoJeC-HPNLb52uO2KDx4zQhPr2GS-X3rs6OAFPN-wYUWpdoz4boQyrl4t6EC=
LpFy3Wg449VFXdumXeDtI72FSHs8vs3bbYqsD2hjY7Fa3eYM30fAwiHVblw9GpynzqkQlnz4AJ1=
Y-prDbbgxwwnE9MBQWqxG6OxohXZscULyxGiDeNTQetDQUDhnFXMPDvsdf5d_Kh5xQQMOq_Nh93=
zT24bZrI1KWpVTs50px1D5ZUHUp0uWOzmuZ6Nz-AVvuEDswUmwRbhuBmZFapoUlXjwLGuRYWmTb=
7vTh7ccA6mgQiNi00dRbvvjio6_GY6ggp6pT4kZQ308RgPIKTZCLJXYxnirSxZfY2qmpYIT1DiN=
BOqTLyW2vUWFSkjGEr2iMi2-8MQWxQHyv5bAW1xYn9eunTHINmlu0MBO1QcSVasj9VR_sJnggeW=
NDI_ut37tsA8WIO623KFb4et2-W3XzyjsY893K4Vm-WUXgXn0jOQRNJiUlV-RIOdH1s1JGOog9d=
zwWDrqgyClrHnPKLxmesDVVg_BgnqqjwQFZdr4fRoDCLXiiQPgRBIqeOsyb99qvmxlLrfXdC6SN=
V5ABWAA1_j4uFMoRa0aiPIiw39bvv5yxf4C6Y5xV-KLU4nHmOzdFNvRA7a6eKhkXmPZ1A8rNq68=
G-6vcupcAUokbxwR61a9qZ9PiBI9pUiDPgB_-LV9QJjgl2n0WUtGpylRv51LqDj8jTTOPPJwR-Z=
cwuawpLn3VjiSOqEUmsJc-en8p9haqPk2oG3IfzWS7pnhU7LEXqU2j4f2N3O1C6ec7jkrnpcMrP=
OCr3xAbPjCyS3WUNhnGd76dNwgWTmlXK5ziMp0ETuW0pNLcB_YUkbeTR8AMUnJeCXc5LJ25vcjU=
N2fWV-muWnvbXvILxp5lWTd_G6nQnLuSUH0ynPhtVClWF0KJkkWxSu20Q4rmulfrPsBfuE9QgKn=
MbhGW39NT1Ya9BHOBrQz87SdUZsk_k59mLCHXsk7pIy7gJuxoJSu6NOz_Zm3S1Se1M77aqDVE0i=
aVVRPjhEVLFJ8weaIvx6gKSbFpLwXq4m2N_tDRiWizwu9o0-EuIMWS0huK64Dpfm0LZPhwRjd8N=
st03TTqWHrD2lzfjlaZ5BQO88wBBl2PjYIxtoMXDgjk=3D )
############################################################
############################################################

--57899cb04cf9603f952a0bc9d5adb4b0830e7f75d6d524e7f485349e700b
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset=utf-8
Mime-Version: 1.0

<!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>MALARIA - VENEZUELA: (FALCON, AMAZONAS) INDIGENOUS PEOPLE<br>********=
*************************************************<br>A ProMED-mail post<br>=
<a href=3D"https://u19268662.ct.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48tisIijp=
efK5PNjW-mL-YZGnfgDOxU1G3gjwnPSi2Tfv3HA/438/Vs5HPoonQT2NystoRFZUlg/h0/wLcGr=
Aq3J5wbeYwx5ITR14fMXeWWMPWufUyMoRfQuaw">http://www.promedmail.org</a><br>Pr=
oMED-mail is a program of the<br>International Society for Infectious Disea=
ses<br><a href=3D"https://u19268662.ct.sendgrid.net/ss/c/wscE2ng5fl6JrPIt48=
tisCT5tpD4Upm3qyMCbcYSQvc/438/Vs5HPoonQT2NystoRFZUlg/h1/Y9seb4PfJkjTp0eYoil=
wVWsslL52ArP3XIae8IglobU">http://www.isid.org</a><br><br>Date: Sun 21 Jan 2=
024=0D<br>Source: El Clar=C3=ADn [machine trans., edited]=0D<br><a href=3D"=
https://u19268662.ct.sendgrid.net/ss/c/u6Jy221DtLTd6phwYNECnZOWpcmRddALc4Yj=
4EqDBaWRA7IySAEFIHq7soR_A2FHs8W-LfId3E95VJqV62El8aARPIdgfVoEzhOXHg97tmRKdYL=
11Q1aaBrmt89iyMr_YHsciqkfATNqYs3-INmaEg/438/Vs5HPoonQT2NystoRFZUlg/h2/2zKcG=
081NV_DXT_PeJ2jvtHauGeP_5z21mZpGtyTQ4c">https://elclarinweb.com/alerta-epid=
emiologica-resurgimiento-mortal-de-malaria-en-comunidades-yanomami/</a>=0D<=
br>=0D<br>=0D<br>Epidemiological alert: deadly resurgence of malaria in Yan=
omami<br>communities=0D<br>------------------------------------------------=
---------------------------=0D<br>Venezuela faces an alarming resurgence of=
 malaria. The report by the<br>NGO SOS Orinoco reveals the tragic reality: =
85 Yanomami indigenous<br>people have lost their lives due to malaria in va=
rious communities in<br>the Sierra Parima, Amazonas State. Names like Momoi=
, Aranai, and<br>Shamauka are now symbols of the devastation this outbreak =
has left in<br>its wake. Epidemiologist Francisco Leal warns that malaria h=
as also<br>become endemic in the state of Falc=C3=B3n, pointing out that th=
is<br>infectious disease persists in the region, permanently affecting the<=
br>population. This situation could lead to Falc=C3=B3n being declared the<=
br>17th Venezuelan state endemic for malaria.=0D<br>=0D<br>The cases are co=
ncentrated in the southern area of western Falcon,<br>specifically in Dabaj=
uro, Buchivacoa and Mene de Mauroa. Health<br>authorities have confirmed 13=
4 cases, 86 of which are native and 48<br>from Zulia. The lack of surveilla=
nce and control of the health system<br>is blamed for the outbreak. Special=
ist Francisco Leal, with his vast<br>experience, points out that the outbre=
ak in Falc=C3=B3n is the result of<br>failures in the surveillance and cont=
rol system. The need to<br>characterize, map and control the case mix of pa=
tients is highlighted<br>as a priority to avoid future episodes.=0D<br>=0D<=
br>The current outbreak marks a grim record for Falc=C3=B3n, being the<br>h=
ighest since 2019. Leal highlights that, since then, there was no<br>certai=
nty about the indigenous nature of the cases, underscoring the<br>urgency o=
f addressing and preventing future outbreaks. The increase in<br>cases and =
deficiencies in the health system response raise questions<br>about the eff=
ectiveness of control measures. The vulnerability of<br>indigenous communit=
ies and the need for immediate action resonate as<br>crucial challenges in =
the fight against malaria.=0D<br>=0D<br>--=0D<br>Communicated by:=0D<br>Pro=
MED=0D<br>via=20=0D<br>ProMED-ESP<br><br>[The history of Venezuela's experi=
ences with malaria is discussed<br>here:=0D<br>=0D<br>Gabald=C3=B3n-Figueir=
a JC, Villegas L, Grillet ME, et al. Malaria in<br>Venezuela: Gabald=C3=B3n=
's legacy scattered to the winds. Lancet Glob<br>Health. 2021 May;9(5):e584=
-e585. doi: 10.1016/S2214-109X(21)00007-3.<br><a href=3D"https://u19268662.=
ct.sendgrid.net/ss/c/0oc7vsq5mmLjPwOs4PjMh3uPKFO3RpoM8Ok2goq-HWzkU27fgRu2nd=
4OA5OjqgxYsLXmRnTp03SNoq7zBFT1iA/438/Vs5HPoonQT2NystoRFZUlg/h3/G-yVojh60NVr=
H0Hf7EHymvNfRu9KV4pCHtqxFWeRYC0">https://pubmed.ncbi.nlm.nih.gov/33865468/<=
/a> (References can be found<br>at the original URL)=0D<br>----------------=
----------------------------------------------------------------=0D<br>"Bet=
ween 1936 and 1970, Venezuela enacted one of the most important<br>sanitary=
 campaigns against malaria. It was led by Arnoldo Gabald=C3=B3n,<br>and its=
 cornerstone was a national indoor residual spraying campaign<br>with dichl=
orodiphenyltrichloroethane that lasted for almost 4 decades.<br>By 1961, ma=
laria had been wiped out from 68% of the Venezuelan<br>territory, and the m=
ortality rate had been reduced from 164 deaths per<br>100=E2=80=88000 peopl=
e in 1936 to zero in 1962 (1,2). The partial<br>elimination of the disease =
earned Venezuela an increase of over<br>400=E2=80=88000 km2 in its commerci=
ally exploitable territory (1). an area<br>twice as large as the UK. This a=
dditional land proved fundamental for<br>Venezuela's economic development d=
uring the 2nd half of the 20th<br>century.=0D<br>=0D<br>The current situati=
on could not be more different: the 2020 World<br>Malaria Report estimates =
that 467=E2=80=88421 cases of malaria occurred in<br>Venezuela in 2019 -- a=
 1200% increase compared with the year 2000 (3).<br>Venezuela's incidence o=
f 32.8 per 1000 people at risk is 8 times<br>higher than that of neighborin=
g Brazil, and comparable to that of<br>Ethiopia (34 cases per 1000 people a=
t risk). Mortality figures are<br>similarly striking. With 403 deaths in 20=
19, Venezuela accounted for<br>73% of the total deaths from malaria estimat=
ed on the continent (3).=0D<br>=0D<br>The epicentre of the epidemic is the =
mining regions south of the<br>Orinoco river (4) where conventional health =
care is often no longer<br>available. This unavailability makes local Ameri=
ndian groups<br>particularly susceptible, given their poor access to preven=
tive<br>measures and antimalarial treatment.=0D<br>=0D<br>The World Malaria=
 Report shows that the situation in Venezuela is<br>anomalous in the global=
 context, with substantial progress achieved<br>elsewhere. Furthermore, the=
 scale of the epidemic, combined with<br>migration from Venezuela into neig=
hboring countries, makes this<br>malaria crisis a regional problem, and is =
driving Latin America<br>severely off track in meeting WHO's milestones for=
 the 2016-30 period.<br>(3,5). If the current trend is sustained, the regio=
n might reach 12<br>cases of malaria per 1000 people at risk by 2030, in st=
riking contrast<br>with the projected reduction in areas with a higher mala=
ria burden.<br>Yet, international attention and support are scant, because =
of a<br>long-outdated understanding of Venezuela as an affluent country.=0D=
<br>=0D<br>Because of the economic gains attained through its oil riches an=
d the<br>exploitation of malaria-free territories in the 1950s, the World B=
ank<br>has long labelled Venezuela as an upper-middle-income country. That<=
br>classification has not been changed, even though the estimated<br>percen=
tage of people living below the extreme poverty line (defined at<br>USD 1.9=
 per day) reached 54=C2=B76% in 2019 (6).=0D<br>=0D<br>The current income c=
lassification is probably out of date. Between<br>2013 and 2020, the Venezu=
elan economy has shrunk by an estimated 74%<br>(7), but the World Bank clas=
sification has yet to account for the last<br>2 years. The newest edition, =
published in July 2020, is based on<br>economic data from mid-2019.(8) If t=
here were full accounting for the<br>past 7 years of economic contraction, =
Venezuela's per-person income<br>would be well under the threshold to be cl=
assified as a lower<br>middle-income country.=0D<br>=0D<br>The upper-middle=
-income classification constrains or, in some cases,<br>outright prohibits =
assistance from key funders of malaria research and<br>control. The Global =
Fund to fight AIDS, Tuberculosis and Malaria for<br>instance, did not consi=
der Venezuela to be eligible for malaria<br>funding until 2019, when it was=
 exceptionally included for the 2020-22<br>allocation period based on its h=
igh malaria burden. At least USD 19.8<br>million is expected to be disburse=
d to the country in 2021 (9).<br>Despite this, Venezuela still is not prior=
itized by other key<br>funders.=0D<br>=0D<br>Furthermore, although the Glob=
al Fund's decision is a key step, there<br>is concern over how the funds wi=
ll be managed, given obstacles<br>ensuring public health neutrality in the =
context of humanitarian<br>crisis and the political control of social aid p=
rogrammes by the<br>Venezuelan Government (10).=0D<br>=0D<br>To ensure a de=
mocratic use of these resources, allocation strategies<br>should involve th=
e Venezuelan medical and scientific community and<br>civil society organiza=
tions in the design, monitoring, and evaluation<br>of any interventions. Go=
vernment participation should be conditional<br>on the release of epidemiol=
ogical data (which has been absent since<br>2016), the cessation of the per=
secution of non-governmental<br>organizations providing humanitarian suppor=
t, and the acceptance of<br>international accountability for disease contro=
l efforts.=0D<br>=0D<br>Paradoxically, we expect malaria cases to decrease =
in 2020, as<br>mobility restrictions, caused by the COVID-19 pandemic and n=
ational<br>fuel shortages, have probably reduced local transmission in mini=
ng<br>sites. Additionally, a few non-governmental organizations together<br=
>with the Pan-American Health Organization have made substantial<br>efforts=
 to distribute insecticide-treated nets in some of the higher<br>burden are=
as, in addition to the tireless surveillance and control<br>endeavors led b=
y indigenous community health agents.=0D<br>=0D<br>The epidemic, however, w=
ill not be brought under control without a<br>functional national malaria p=
rogram in place. Ironically, it was the<br>success of such a previous progr=
am that led to the economic boom now<br>preventing Venezuelan researchers f=
rom accessing urgently needed<br>resources. It is time for this painful iro=
ny to end." - Mod.LL<br><br>ProMED map:<br>Venezuela: <a href=3D"https://u1=
9268662.ct.sendgrid.net/ss/c/sSnCkKCWBvais3EuVAOvgy2WOIX7pp1nXnn4AbwuQ3Z6Wb=
kfhqXYXU-aTMPJ8yThc-I-62tor5dVH1LSD9qPzg/438/Vs5HPoonQT2NystoRFZUlg/h4/Khe5=
xuKzmDGhRJHoGf08aSqbwESCZvfwUjlDherD9jA">https://promedmail.org/promed-post=
?place=3D8714399,29</a>]<br><br>[See Also:<br>Malaria - Argentina: (Buenos =
Aires) imported, USA citizen, fatal<br>http://promedmail.org/post/20240118.=
8714316=0D<br>Malaria - Cape Verde: elimination, WHO<br>http://promedmail.o=
rg/post/20240117.8714283=0D<br>Malaria - USA (01): (OR) falciparum, probabl=
e prolonged presentation,<br>ex Africa, 2022 http://promedmail.org/post/202=
40113.8714202=0D<br>Malaria - Tanzania: (Zanzibar) re-emergence<br>http://p=
romedmail.org/post/20240113.8714213=0D<br>2023=0D<br>----=0D<br>Malaria - A=
sia (09): India (WB)<br>http://promedmail.org/post/20231215.8713751=0D<br>M=
alaria - Asia (07): India (TR) increased cases<br>http://promedmail.org/pos=
t/20231018.8712705=0D<br>Malaria - Americas (16): USA (MD) autochthonous, f=
alciparum, CDC<br>http://promedmail.org/post/20231012.8712600=0D<br>Malaria=
 - Americas (15): (Canada) ex Philippines, Plasmodium knowlesi<br>http://pr=
omedmail.org/post/20231007.8712508=0D<br>Malaria - Americas (14): USA (AR) =
autochthonous<br>http://promedmail.org/post/20231005.8712469=0D<br>Malaria =
- Africa (07): Ethiopia (OR) continued increase, RFI<br>http://promedmail.o=
rg/post/20231001.8712408=0D<br>Malaria - Americas (13): Costa Rica (PU)<br>=
http://promedmail.org/post/20230929.8712370=0D<br>Malaria - Americas (12): =
USA (FL, TX) CDC<br>http://promedmail.org/post/20230908.8712013=0D<br>Malar=
ia - Americas (11): USA (MD) 1st report in 40 years<br>http://promedmail.or=
g/post/20230819.8711760=0D<br>Malaria - Americas (11): Colombia, increase i=
n incidence<br>http://promedmail.org/post/20230723.8711323=0D<br>Malaria - =
Americas (10): USA (FL) autochthonous<br>http://promedmail.org/post/2023071=
8.8711230=0D<br>Malaria - Americas (09): USA (FL, TX) autochthonous, update=
<br>http://promedmail.org/post/20230709.8711042=0D<br>Malaria - Africa (06)=
: Ethiopia, increase, RFI<br>http://promedmail.org/post/20230706.8710994=0D=
<br>Malaria - Americas (08): USA (FL, TX) autochthonous, CDC, alert<br>http=
://promedmail.org/post/20230629.8710856=0D<br>Malaria - Americas (07): USA =
(TX) autochthonous<br>http://promedmail.org/post/20230625.8710761=0D<br>Mal=
aria - Americas (06): USA (FL) autochthonous, RFI<br>http://promedmail.org/=
post/20230623.8710719=0D<br>Malaria - Africa (05): Kenya (MB) fatal, not li=
nked to Anopheles<br>stephensi http://promedmail.org/post/20230524.8710210=0D=
<br>Malaria - Africa (04): Kenya (BN), Congo DR (KS), Nigeria (AN), Ghana<b=
r>http://promedmail.org/post/20230502.8709805=0D<br>Malaria - Americas (05)=
: Colombia, Venezuela<br>http://promedmail.org/post/20230501.8709785=0D<br>=
Malaria - Americas (04): USA, imported, ex Liberia, fatal<br>http://promedm=
ail.org/post/20230427.8709737=0D<br>Malaria - Americas (03): (Costa Rica, P=
anama)<br>http://promedmail.org/post/20230424.8709665=0D<br>Malaria - Ameri=
cas (02): Costa Rica (LI)<br>http://promedmail.org/post/20230409.8709416=0D=
<br>Malaria - Americas: Panama, increase<br>http://promedmail.org/post/2023=
0315.8708952]<br>.................................................jt/ll/may=
/jh<br></body>
</html><!DOCTYPE HTML>
<html>
<head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3DUTF-8" />
</head>
<body>*##########################################################*<br>*****=
*******************************************************<br>ProMED makes eve=
ry effort to verify the reports that are posted, but the accuracy<br>and co=
mpleteness of the information, and of any statements or opinions based<br>t=
hereon, are not guaranteed. The reader assumes all risks in using informati=
on<br>posted or archived by ProMED. ISID and its associated service provide=
rs shall not<br>be held responsible for errors or omissions or held liable =
for any damages incurred<br>as a result of use or reliance upon posted or a=
rchived material.<br>******************************************************=
******<br>Donate to ProMED. Details available at: https://isid.networkforgo=
od.com/projects/79924-invest-in-the-mission.<br>***************************=
*********************************<br>Visit ProMED's website at https://www.=
promedmail.org/.<br>Submit all items for posting via the ProMED website at =
https://promedmail.org/submitinfo/.<br>If you have any questions or need su=
pport, please contact us via the ProMED website at  https://promedmail.org/=
support/.<br>You may subscribe/unsubscribe at  https://isid.org/promedmail-=
subscribe/.<br><div><a href=3D"https://u19268662.ct.sendgrid.net/asm/?user_=
id=3D19268662&amp;data=3DectqUzjpxOCQdwBqe10mLlG10Fgk9llFN9qxAE_jsypoMDAwdT=
AwMLZ61lEVOG2qTCLLXH7FICaoJeC-HPNLb52uO2KDx4zQhPr2GS-X3rs6OAFPN-wYUWpdoz4bo=
Qyrl4t6ECLpFy3Wg449VFXdumXeDtI72FSHs8vs3bbYqsD2hjY7Fa3eYM30fAwiHVblw9Gpynzq=
kQlnz4AJ1Y-prDbbgxwwnE9MBQWqxG6OxohXZscULyxGiDeNTQetDQUDhnFXMPDvsdf5d_Kh5xQ=
QMOq_Nh93zT24bZrI1KWpVTs50px1D5ZUHUp0uWOzmuZ6Nz-AVvuEDswUmwRbhuBmZFapoUlXjw=
LGuRYWmTb7vTh7ccA6mgQiNi00dRbvvjio6_GY6ggp6pT4kZQ308RgPIKTZCLJXYxnirSxZfY2q=
mpYIT1DiNBOqTLyW2vUWFSkjGEr2iMi2-8MQWxQHyv5bAW1xYn9eunTHINmlu0MBO1QcSVasj9V=
R_sJnggeWNDI_ut37tsA8WIO623KFb4et2-W3XzyjsY893K4Vm-WUXgXn0jOQRNJiUlV-RIOdH1=
s1JGOog9dzwWDrqgyClrHnPKLxmesDVVg_BgnqqjwQFZdr4fRoDCLXiiQPgRBIqeOsyb99qvmxl=
LrfXdC6SNV5ABWAA1_j4uFMoRa0aiPIiw39bvv5yxf4C6Y5xV-KLU4nHmOzdFNvRA7a6eKhkXmP=
Z1A8rNq68G-6vcupcAUokbxwR61a9qZ9PiBI9pUiDPgB_-LV9QJjgl2n0WUtGpylRv51LqDj8jT=
TOPPJwR-ZcwuawpLn3VjiSOqEUmsJc-en8p9haqPk2oG3IfzWS7pnhU7LEXqU2j4f2N3O1C6ec7=
jkrnpcMrPOCr3xAbPjCyS3WUNhnGd76dNwgWTmlXK5ziMp0ETuW0pNLcB_YUkbeTR8AMUnJeCXc=
5LJ25vcjUN2fWV-muWnvbXvILxp5lWTd_G6nQnLuSUH0ynPhtVClWF0KJkkWxSu20Q4rmulfrPs=
BfuE9QgKnMbhGW39NT1Ya9BHOBrQz87SdUZsk_k59mLCHXsk7pIy7gJuxoJSu6NOz_Zm3S1Se1M=
77aqDVE0iaVVRPjhEVLFJ8weaIvx6gKSbFpLwXq4m2N_tDRiWizwu9o0-EuIMWS0huK64Dpfm0L=
ZPhwRjd8Nst03TTqWHrD2lzfjlaZ5BQO88wBBl2PjYIxtoMXDgjk=3D" target=3D"_blank" =
class=3D"Unsubscribe--unsubscribePreferences" style=3D"font-family:sans-ser=
if;text-decoration:none;">Unsubscribe Preferences</a></div><br>############=
################################################<br>#######################=
#####################################<br><br><img src=3D"https://u19268662.=
ct.sendgrid.net/ss/o/LbtalBvHhFtzyiegKfBhew/438/Vs5HPoonQT2NystoRFZUlg/ho.g=
if" alt=3D"" width=3D"1" height=3D"1" border=3D"0" style=3D"height:1px !imp=
ortant;width:1px !important;border-width:0 !important;margin-top:0 !importa=
nt;margin-bottom:0 !important;margin-right:0 !important;margin-left:0 !impo=
rtant;padding-top:0 !important;padding-bottom:0 !important;padding-right:0 =
!important;padding-left:0 !important;"/></body>
</html>
--57899cb04cf9603f952a0bc9d5adb4b0830e7f75d6d524e7f485349e700b--
